| Literature DB >> 23657136 |
Alexandra Christopher, Stephen E Mshana, Benson R Kidenya, Aldofineh Hokororo, Domenica Morona.
Abstract
BACKGROUND: Antibiotic resistance is one of the most serious public health concerns worldwide and is increasing at an alarming rate, making daily treatment decisions more challenging. This study is aimed at identifying local bacterial isolates and their antimicrobial susceptibility patterns to avoid irrational antibiotic use, especially in settings where unguided management occurs and febrile illnesses are predominant.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23657136 PMCID: PMC3665601 DOI: 10.1186/1824-7288-39-27
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Figure 1Flow chart showing children studied and magnitude of different outcome.
Showing demographic characteristics
| | |
| ≤36 | 251 (79.2) |
| >36 | 66 (20.8) |
| | |
| Male | 195 (61.5) |
| Female | 122 (38.5) |
| | |
| No | 257 (81.1) |
| Yes | 60 (18.9) |
| | |
| No | 70 (22.2) |
| Yes | 247 (77.8) |
| | |
| No | 274 (86.4) |
| Yes | 43 (13.6) |
| | |
| No | 308 (97.2) |
| Yes | 9 (2.8) |
| | |
| No | 311 (98.1) |
| Yes | 6 (1.9) |
| | |
| No | 301 (94.9) |
| Yes | 16 (5.1) |
susceptibility pattern of 20 gram negative isolates from febrile children (N = 317)
| R | S | R | S | S | S | R | R | R | S | S | S | S | ||
| S | R | R | S | R | S | S | R | R | S | S | S | S | ||
| R | S | R | S | R | S | R | R | R | S | S | S | S | ||
| R | R | R | S | R | R | S | R | R | R | R | R | S | ||
| S | S | R | S | S | S | R | R | S | S | S | S | S | ||
| R | S | R | S | R | S | R | R | R | S | S | S | S | ||
| R | R | R | S | R | S | R | R | R | S | S | S | S | ||
| R | R | R | R | R | S | R | R | R | S | S | S | S | ||
| R | S | R | R | R | S | R | R | R | S | S | S | S | ||
| R | S | R | R | R | S | R | R | R | R | R | R | S | ||
| R | R | R | S | R | S | R | R | R | R | R | R | S | ||
| R | S | R | R | R | S | R | R | R | S | S | S | S | ||
| R | S | R | R | R | S | R | R | R | S | S | S | S | ||
| R | S | R | S | R | S | R | R | R | R | NA | NA | S | ||
| R | R | R | R | R | R | R | R | R | S | NA | NA | S | ||
| S | S | S | S | R | S | S | R | R | S | S | S | |||
| S | S | S | S | S | S | S | R | S | S | S | S | |||
| R | S | R | S | R | S | S | R | R | R | R | R | S | ||
| R | S | R | S | R | S | S | R | R | R | R | R | S | ||
| R | S | R | S | R | S | S | R | R | S | S | S | S | ||
| R | R | R | S | R | S | R | R | R | NA | NA | NA | S |
A; ampicillin, AMC; amoxyillin/clavunate, CIP; ciprofloxacin, TET; tetracycline, G; gentamicin, SXT; sulfamethoxazole/ trimethoprim, CRO; ceftriaxone, CAZ; ceftazidime, AK: amikacin, MEM; meropenem, NO; Norfloxacin, C; chloramphenicol and CTX; Cefotaxime. R; resistant, S; sensitive. * ESBL producer, NA; Not applicable, S: Inducible resistance is expected. S; Salmonella spp may test susceptible in vitro but the drug is ineffective in vivo. Isolate no 60 was tested with cefoxitin and oxacillin and found to be sensitive so it is not MRSA.
Showing predictors of bacteremia
| ≤38.5°C | 6 (2.6) | 225 (97.4) | 1 | | | |
| >38.5°C | 15 (17.4) | 71 (82.6) | 7.9 (2.9-21.2) | 0.0001 | 13 (3.5-54) | 0.0001 |
| No | 17 (6.5) | 244 (93.5) | 1 | | | |
| Yes | 4 (7.1) | 52 (92.9) | 1.1 (0.4-3.4) | 0.86 | - | - |
| No | 18 (8.1) | 204 (91.9) | 1 | | | |
| Yes | 3 (3.2) | 92 (96.8) | 0.4 (0.1-1.3) | 0.12 | 0.9 (0.2-3.9) | 0.8 |
| No | 16 (6.2) | 244 (93.8) | 1 | | | |
| Yes | 5 (8.7) | 52 (91.3) | 1.5 (0.5-4.2) | 0.48 | - | - |
| No | 16 (5.8) | 260 (94.2) | 1 | | | |
| Yes | 5 (12.2) | 36 (87.8) | 2.2 (0.7-6.5) | 0.13 | 1.3 (0.3-5.8) | 0.7 |
| No | 20 (6.6) | 282 (93.4) | 1 | | | |
| Yes | 1 (7.7) | 12 (92.3) | 1.2 (0.2-9.5) | 0.88 | - | - |
| No | 7 10.0) | 63 (90.0) | 1 | | | |
| Yes | 14 (5.7) | 231 (94.3) | 0.6 (0.2-1.4) | 0.21 | - | - |
| No | 7 (3.2) | 212 (96.8) | 1 | | | |
| Yes | 13 (15.8) | 69 (84.2) | 5.7 (2.2-14.8) | 0.0001 | 14 (3.5-60) | 0.0001 |
| No | 15 (5.5) | 259 (94.5) | 1 | | | |
| Yes | 6 (13.9) | 37 (86.1) | 2.8 (1.0-7.7) | 0.04 | 1 (0.3-4.4) | 0.9 |
| No | 19 (7.4) | 238 (92.6) | 1 | | | |
| Yes | 2 (3.3) | 58 (96.7) | 0.4 (0.1-1.9) | 0.26 | - | - |
| ≤10000 c/l | 6 (2.4) | 245 (97.6) | 1 | | | |
| >10000 c/l | 15 (26.3) | 42 (73.7) | 14 (5.4-39.7) | 0.0001 | 21 (5.6-84) | 0.0001 |
Showing bacteremia and complete blood count
| | Positive Median (IQR) | Negative Median (IQR) | |
| Total WBC c/l *103 | 16.1 (11–21.8) | 9.1 (5.7-13.5) | 0.0001 |
| Lymphocytes c/l | 2990 (2178–4379) | 2522.5 (190–5130) | 0.3935 |
| Thrombocytes *109/l | 397 (226.5-529) | 370 (242–507) | 0.7374 |
| *Hemoglobin g/dl | *7.4 ± 2.6 | *8.4 ± 2.6 | 0.04 |
* For hemoglobin the mean ± Standard Deviation.